InvestorsHub Logo
Followers 797
Posts 50895
Boards Moderated 1
Alias Born 12/12/2004

Re: crudeoil24 post# 1688

Monday, 09/13/2021 12:57:37 PM

Monday, September 13, 2021 12:57:37 PM

Post# of 1722
Shares of Cardiff Oncology Inc. are trading higher. The company released new data on its lead clinical program evaluating onvansertib to treat certain colorectal cancer patients.

Cardiff Oncology said the program is evaluating onvansertib in combination with standard-of-care Folfiri/bevacizumab to treat certain colorectal cancer patients.

"Our Phase 1b/2 trial continues to generate data suggesting that the addition of onvansertib to SOC results in an objective response rate and median progression-free survival that substantially exceed those previously achieved with SOC alone," said Katherine L. Ruffner, chief medical officer.

New York Yankees and Duke Basketball

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDF News